서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 48 of 48

Issue DateTitle / Author(s) / CitationFileAltmetrics
1990-03
Pharmacokinetics of Amitriptyline Demethylation;A Crossover Study with Single Doses of Amitriptyline and Nortriptyline
view file
2005-05
Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer
link
2005-05
Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer
link
2005-06
Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers
link
2005-10
Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers
link
2006-06
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
view filelink
2006-06
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
view filelink
2006-06
YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases
link
2006-07
Genetic polymorphisms of eNOS, hormone receptor status, and survival of breast cancer
link
2006-09
Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study
link
2006-09
Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study
link
2006-12
Angiotensin II type 1 receptor 1166A/C polymorphism in association with blood pressure response to exogenous angiotensin II
link
2007-09
Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer
link
2008-03
Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects
link
2008-03
Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects
link
2008-08
Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjects
link
2008-09
Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole
link
2008-11
Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study
link
2008-11
Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients
link
2008-11
Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients
link
2008-12
Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma
link
2009-04
Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused by Plasmodium vivax
DOI
2009-07
Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma

Kim, Won; Yoon, Jung-Hwan; Kim, Jung-Ryul; Jang, In-Jin; Bang, Yung-Jue; Kim, Yoon-Jun; Lee, Hyo-Suk

Cancer Chemotherapy and Pharmacology, Vol.64 No.3, pp.497-507

DOI
2009-08
Pharmacokinetics of Intravenous Piperacillin Administration in Patients Undergoing On-Line Hemodiafiltration
DOI
2009-10
Optimal dose of intravenous pantoprazole in patients with peptic ulcer bleeding requiring endoscopic hemostasis in Korea

Choi, Kee Don; Kim, Nayoung; Jang, In-Jin; Park, Young Soo; Kim, Jung-Ryul; Jung, Hyun Chae; Song, In Sung; Shin, Jai Moo; Cho, Joo Youn

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY; Vol.24 10; 1617-1624

DOI
2009-11
Unpredictable Pharmacokinetics of Once-Daily Intravenous Busulfan When Combined with Fludarabine in Pediatric Patients: Phase I Clinical Study for Determination of Optimal Once-Daily Busulfan Dose Using Pharmacokinetic Modeling.
2009-12
Gastroprotective Action of Cochinchina Momordica Seed Extract Is Mediated by Activation of CGRP and Inhibition of cPLA(2)/5-LOX Pathway
DOI
2011-01
Effects of Pregnane X Receptor (NR1I2) and CYP2B6 Genetic Polymorphisms on the Induction of Bupropion Hydroxylation by Rifampin
DOI
2011-10
Immunogenicity and safety of a single intramuscular dose of a diphtheria-tetanus toxoid (Td) vaccine (GC1107) in Korean adults
DOI
2012-01
Voriconazole-associated severe hyponatremia
DOI
2012-10
The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
DOI
2014-07
A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HIVI30181A, in Patients with Advanced Solid Cancer
DOI
2015-01
ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy
DOI
2015-08
Pharmacokinetics of second-line antituberculosis drugs after multiple administrations in healthy volunteers
DOI
2015-10
Rapid Hepatobiliary Excretion of Micelle-Encapsulated/Radiolabeled Upconverting Nanoparticles as an Integrated Form
view fileDOI
2016-01
Phase I study of CKD-516, a novel vascular disrupting agent, in patients with advanced solid tumors
DOI
2018-02
Assessment of appropriateness of an initial dosing regimen of vancomycin and development of a new dosing nomogram

Yoon, Seonghae; Park, Kyoung Ryun; Lee, SeungHwan; Song, Sang-Hoon; Park, Wan Beom; Jang, In-Jin; Yu, Kyung-Sang

Basic and Clinical Pharmacology and Toxicology, Vol.122 No.2, pp.233-238

DOI
2018-12
Assessment of hepatic cytochrome P450 3A activity using metabolic markers in patients with renal impairment
DOI
2019-02
A Personalized CYP2C19 Phenotype-Guided Dosing Regimen of Voriconazole Using a Population Pharmacokinetic Analysis

Kim, Yun; Rhee, Su-jin; Park, Wan Beom; Yu, Kyung-Sang; Jang, In-Jin; Lee, Seunghwan

Journal of Clinical Medicine, Vol.8 No.2, p. 227

DOI
2019-06
Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea
DOI
2019-09
Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial
DOI
2019-10
ST2 blockade mitigates peritoneal fibrosis induced by TGF-β and high glucose
DOI
2022-01
Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole
DOI
2022-06
Comparative pharmacokinetics between two tablets of tramadol 37.5 mg/acetaminophen 325 mg and one tablet of tramadol 75 mg/ acetaminophen 650 mg for extended-release fixed-dose combination

Kim, Hyun Chul; Yoon, Deok Yong; Lee, Seunghwan; Jang, In-Jin; Hong, Jang Hee; Kim, Jaewoo

Translational and Clinical Pharmacology, Vol.30 No.2, pp.112-119

DOI
2022-08
Dose-dependent reduction of lymphocyte count and heart rate after multiple administration of LC51-0255, a novel sphingosine-1-phosphate receptor 1 modulator, in healthy subjects

Hwang, Inyoung; Lee, Sang Won; Oh, Jaeseong; Lee, SeungHwan; Jang, In-Jin; Yu, Kyung-Sang

Frontiers in Pharmacology, Vol.13, p. 930615

DOI
2022-09
The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects

Hwang, Sejung; Lee, Soyoung; Kim, Eunwoo; Hwang, Inyoung; Cho, Joo-Youn; Chung, Jae-Yong; Jang, In-Jin; Oh, Jaeseong

Clinical and Translational Science, Vol.15 No.9, pp.2116-2126

DOI
2022-09
Dose-dependent glucosuria of DWP16001, a novel selective sodium–glucose cotransporter-2 inhibitor, in healthy subjects

Hwang, Jun Gi; Lee, SeungHwan; Huh, Wan; Han, Jumi; Oh, Jaeseong; Jang, In-Jin; Yu, Kyung-Sang

British Journal of Clinical Pharmacology, Vol.88 No.9, pp.4100-4110

DOI
2023-06
Effect of haemodialysis on the pharmacokinetics and pharmacodynamics of evogliptin
DOI
1